NICE and NHS guidance does not include it as a recommended treatment, unlike licensed options such as topical minoxidil and finasteride
The FDA peptide vote 2026 therefore includes a separate list-inclusion question for each form, even when both receive the same tally
Cardiovascular markers Both compounds showed improvements in cardiovascular risk markers in their respective trials
This guide breaks down every meaningful difference between tirzepatide and retatrutide, from receptor pharmacology to clinical trial results, dosing protocols , side effect profiles, and practical availability
Any current use is off-label, compounded, and should be supervised by a licensed medical provider
Less Common Side Effects Dizziness or fatigue: Some patients report lightheadedness or unusual tiredness after injection